Proteins are an important class of biological macromolecules composed of amino acids present in living organisms. They play a variety of important roles, including participating in the metabolism, transportation, and transmission of nerve impulses in the body in organisms, and they are important molecules necessary to maintain life activities. Peptides are proteins of low molecular weight, usually consisting of less than 50 amino acid residues. Similar to proteins, peptides also play various important biological roles.
Ace Therapeutics offers hundreds of natural and recombinant proteins & peptides for stroke research, including but not limited to, cytokines, neuroprotective proteins, apoptotic factors, and inflammatory mediators.
Importantly, each of our products is verified by standard quality control procedures and tested for biological activity and low endotoxicity.
Please access our all-series proteins & peptides or contact our scientist for personalized assistance.
| Cat.# | Name | Size | Description | Price |
|---|---|---|---|---|
| ACPP-1316 | GPCR GPR7 Blocking Peptide (AC1316) | 250 µg |
GPCR GPR7 Blocking Peptide for Immunodepletion, Immunocompetition
|
inquiry |
| ACPP-1317 | Noelin Blocking Peptide (AC1317) | 250 µg |
Noelin Blocking Peptide for Immunocompetition, Immunodepletion
|
inquiry |
| ACPP-1318 | Orexin A Blocking Peptide (AC1318) | 250 µg |
Orexin A Blocking Peptide for Immunodepletion, Immunocompetition
|
inquiry |
| ACPP-1319 | Axin 2 Blocking Peptide (AC1319) | 250 µg |
Axin 2 Blocking Peptide for Immmunodepletion, Competition Assay
|
inquiry |
| ACPP-1320 | FGFR4 Blocking Peptide (AC1320) | 250 µg |
FGFR4 Blocking Peptide for Immunodepletion, Immunocompetition
|
inquiry |
| ACPP-1321 | NPY5R Blocking Peptide (AC1321) | 250 µg |
NPY5R Blocking Peptide for Immunocompetition, Immunodepletion
|
inquiry |
| ACPP-1322 | TRPM8 Blocking Peptide (AC1322) | 250 µg |
TRPM8 Blocking Peptide for Immunocompeition, Immunodepletion
|
inquiry |
| ACPP-1323 | FYN Blocking Peptide (AC1323) | 250 µg |
FYN Blocking Peptide for Immunodepletion, Immunocompetition
|
inquiry |
| ACPP-1324 | Insulin Receptor Blocking Peptide (AC1324) | 250 µg |
Insulin Receptor Blocking Peptide for Immunocompetition, Immunodepletion
|
inquiry |
| ACPP-1325 | Synaptotagmin 1 Blocking Peptide (AC1325) | 250 µg |
Synaptotagmin 1 Blocking Peptide for Immunocompetition, Immunodepletion
|
inquiry |
| ACPP-1326 | Galectin 3 Blocking Peptide (AC1326) | 250 µg |
Galectin 3 Blocking Peptide for Immmunodepletion, Competition Assay
|
inquiry |
| ACPP-1327 | Dopamine Receptor D1 Blocking Peptide (AC1327) | 250 µg |
Dopamine Receptor D1 Blocking Peptide for Immunodepletion, Immunocompetition
|
inquiry |
| ACPP-1328 | MRAP2 Blocking Peptide (AC1328) | 250 µg |
MRAP2 Blocking Peptide for Immunocompetition, Immunodepletion
|
inquiry |
| ACPP-1329 | PDE6 Beta Blocking Peptide (AC1329) | 250 µg |
PDE6 Beta Blocking Peptide for Immunodepletion, Immunocompetition
|
inquiry |
| ACPP-1330 | PAX2 Blocking Peptide (AC1330) | 250 µg |
PAX2 Blocking Peptide for Immunodepletion, Immunocompetition
|
inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.